Risk factors for endometrial polyps to transform into endometrial cancer: insights from a bibliometric analysis

子宫内膜息肉转化为子宫内膜癌的危险因素:文献计量分析的启示

阅读:2

Abstract

BACKGROUND: Endometrial polyps (EPs) are at risk of transforming into endometrial cancer (EC). Terminal EC seriously affects women's quality of life and places a heavy financial burden on families. Investigating the risk factors that influence the conversion of EPs to EC and preventing them from progressing further is crucial. This study attempts to map the features of published literature on risk factors and understand the frontiers and hotspots of that research by using bibliometric analysis. METHODS: We obtained relevant publications from 1996 to 2024 from the Web of Science Core Collection (WoSCC) on July 11, 2024. Next, CiteSpace software, the R (Version 4.3.2) package Bibliometrix, the Online Analysis Platform of Document Metrology ( http://biblimetric.com ), and a web interface for Bibliometrix were used to analyse the data. RESULTS: The analysis included 90 qualifying data points concerning the risk factors for the conversion of EPs to EC. The American Journal of Obstetrics and Gynecology was the most productive publication. The authors referenced the most were Cohen I and Ferrazzi E. After removing similar keywords, the keywords that did not have a specific meaning, the remaining keywords mainly included hysteroscopy, postmenopausal women, premenopausal, therapy, diagnosis, patients receiving tamoxifen, ultrasound, and management. The long-term management of EPs has emerged as a new research hotspot, per the trend topic. CONCLUSIONS: In the published literature, age, perimenopause and postmenopausal bleeding are the most frequently studied factors for the conversion of EPs to EC, also including PCOS and polyp size. Endometrial polypectomy and long-term management may be recommended for these patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。